Past projects
Until our vision to find a vaccine to protect against all types of meningitis is realised, our urgent mission will continue. But thanks to the support of people such as yourselves, we have already come a long way. Here are some of the previous projects we have been involved in, which add up to a total investment of £1,736,894.
Identifying proteins on meningitis B bacteria that are important in stimulating protective immune responses
Professor John Heckels, University of Southampton
Studying the potential of meningitis B secreted proteins for use in a vaccine
Dr Karl Wooldridge, University of Nottingham
A vaccine against serogroup B meningococcal disease: from the laboratory to clinical trials
Professor Andrew Pollard, University of Oxford
Human immune response to experimental colonisation with Neisseria lactamica
Professor Robert Read, University of Sheffield
Identifying groups of meningitis C bacteria which may become resistant to antibodies produced by the current vaccine
Professor Christoph Tang, Centre for Molecular Microbiology and Infection, London
Developing new methods to assess immunity to pneumococcus after vaccination
Dr Helen Baxendale, Institute of Child Health, London
How does the immune system react to meningitis B bacteria and what do we need for a successful whole-cell vaccine?
Professor Robin Callard, Institute of Child Health, London
Developing a Lipopolysaccharide vaccine against meningitis B bacteria
Professor Richard Moxon, University of Oxford
Developing a new treatment for heart failure caused by meningococcal infection
Professor Michael Levin, Imperial College London
Identification of meningococcal antigens associated with development of cross-reactive immunity following colonisation and infection
Professor John Heckels, University of Southampton
A protein vaccine against serogroup B meningococcal disease: from proof in principle to phase I clinical trials
Professor Andrew Pollard, University of Oxford
Human immune response to experimental colonisation with Neisseria lactamica at University of Sheffield
Professor Robert Read, University of Sheffield
Characterisation of serogroup CN meningitidis strains resistant to killing by anti-capsular antibodies
Professor Christoph Tang, Centre for Molecular Microbiology and Infection, London
Developing new techniques to assess the nature and duration of protective immunity to pneumococcus after vaccination
Dr Helen Baxendale, Institute of Child Health, London
Development of a meningococcal hyperinvasive lineage specific recombinant protein vaccine
Professor Andrew Pollard, University of Oxford
Engineering Group B Neisseria meningitidis for an effective whole bacteria vaccine: Critical determinants for dendritic cell activation and antigen presentation
Professor Robin Callard, Institute of Child Health, London
Development of a Lipopolysaccahride-based conjugate vaccine to prevent Neisseria meningitides serogroup B invasive disease
Professor Richard Moxon, University of Oxford
Development of a novel therapy for myocardial depression in meningococcal septic shock inhibition of a small protein called interleukin 6 (IL6)
Professor Michael Levin, Imperial College London
MeningitisUK · Registered Charity No.1076774